-+ 0.00%
-+ 0.00%
-+ 0.00%

Monopar Therapeutics holds annual shareholder meeting

PUBT·06/23/2026 12:01:55
Listen to the news
Monopar Therapeutics holds annual shareholder meeting
  • Monopar Therapeutics held its annual meeting on June 22, 2026.
  • Shareholders backed the slate of director nominees, setting board membership until the next annual meeting.
  • Investors adopted the 2026 Stock Incentive Plan.
  • Shareholders ratified BPM LLP as independent registered public accounting firm for the year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monopar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021350), on June 23, 2026, and is solely responsible for the information contained therein.